See how a robotic-assisted innovation could help with knee-replacement surgery
Over three million people have knee-replacement surgery each year. The VELYSTM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.
Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 56 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.
Plaque psoriasis is the most prevalent form of psoriasis, affecting millions worldwide. Johnson & Johnson is focused on developing novel therapies for chronic dermatologic diseases to address the unmet need that still exists.
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.